Malaysia ranks among world's top offshore manufacturing hubs for medical devices, says report
Malaysia has established itself as one of the world's top offshore manufacturing hubs for medical devices, with close to 300 medical device manufacturing companies undertaking a variety of activities ranging from regional headquarters and manufacturing to research and development (R&D).
马来西亚已成为世界顶级医疗器械离岸制造中心之一，拥有近 300 家医疗器械制造公司，从事从区域总部和制造到研发 (R&D) 的各种活动.
In a statement on 14th November in conjunction with the Association of Malaysian Medical Industries (AMMI) Medical Device Industry Status and Outlook 2021/2022 Report, the Malaysian Investment Development Authority (MIDA) and AMMI said 10 out of the top 30 global medical technology have set up manufacturing in Malaysia, and thus puts the country in the company of Puerto Rico, Ireland and Costa Rica offshore manufacturing hubs.
马来西亚投资发展局（MIDA）和 AMMI 在11 月 14 日与马来西亚医疗工业协会（AMMI）医疗器械行业现状和展望 2021/2022 报告一起发表的声明中表示，全球前 30 名中有 10 家medical technology 已在马来西亚设立制造厂，从而使该公司成为该国在波多黎各、爱尔兰和哥斯达黎加的离岸制造中心。
MIDA chief executive officer Datuk Wira Arham Abdul Rahman said that since 2015, AMMI has collaborated closely with MIDA to foster the development of the country's medical device industry.
MIDA 首席执行官 Datuk Wira Arham Abdul Rahman 表示，自 2015 年以来，AMMI 与 MIDA 紧密合作，以促进该国医疗器械行业的发展。
“AMMI has helped the industry's major companies organise training programmes, which have benefited 2,647 Malaysians and increased their chances of securing better jobs.
“AMMI 已帮助该行业的主要公司组织培训计划，使 2,647 名马来西亚人受益，并增加了他们获得更好工作的机会。
“AMMI has helped promote Malaysia as a prospective investment destination in this region and Asia, attracting the attention of major international firms in the medical device industry.
“AMMI 帮助推动马来西亚成为该地区和亚洲的潜在投资目的地，吸引了医疗器械行业主要国际公司的关注。
“MIDA also plays the role of mediator between the companies and local regulators, ensuring the quality standards and requirements match the global demand," he said.
“MIDA 还在公司和当地监管机构之间扮演调解人的角色，确保质量标准和要求符合全球需求，”他说。
Meanwhile, AMMI chairman Andy Lee said Malaysia will continue to attract more foreign direct investment in medical device manufacturing with the ratification of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP).
与此同时，AMMI 主席 Andy Lee 表示，随着跨太平洋伙伴关系全面进步协议（CPTPP）的批准，马来西亚将继续吸引更多外国直接投资于医疗器械制造。
He said AMMI believes that the industry has the potential to scale even further and capitalise on the global medical device market, which is expected to reach US$745 billion (RM3.4 trillion) by 2030.
他说，AMMI 认为该行业有潜力进一步扩大规模并利用全球医疗器械市场，预计到 2030 年该市场将达到 7450 亿美元（3.4 万亿令吉）。
He said that in the pandemic era, AMMI members' investment levels in Malaysia continued to grow, adding that 63% of its members indicate future development plans, and that this trend is expected to continue in the coming years.
他说，在疫情时代，AMMI成员在大马的投资水平持续增长，并补充说，63%的成员表示有未来的发展计划，预计这趋势在未来数年会持续。